These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1154342)

  • 1. Plasma antithrombin III: a quantitative assay of biological activity.
    Gitel SA; Wessler S
    Thromb Res; 1975 Jul; 7(1):5-16. PubMed ID: 1154342
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombin III, heparin cofactor and antifactor Xa in a clinical material.
    Odegård OR; Teien AN
    Thromb Res; 1976 Feb; 8(2):173-8. PubMed ID: 56054
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombin assay - the use of human or bovine thrombin and the observation of a "second" heparin cofactor.
    Friberger P; Egberg N; Holmer E; Hellgren M; Blombäck M
    Thromb Res; 1982 Mar; 25(5):433-6. PubMed ID: 7071813
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombin 3, antifactor Xa and heparin.
    Biggs R; Denson KW; Akman N; Borrett R; Hadden M
    Br J Haematol; 1970 Sep; 19(3):283-305. PubMed ID: 5529547
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
    Sakata T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
    [No Abstract]   [Full Text] [Related]  

  • 6. The rabbit as an animal model for the activated factor X-antithrombin III-heparin reaction.
    Gitel SN; Wessler S; Medina VM
    Circ Res; 1977 Aug; 41(2):187-91. PubMed ID: 872292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
    Seegers WH
    Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma antithrombins during heparin therapy.
    Boneu B; Sie P; Caranobe C; Guittard J
    Thromb Res; 1982 Jul; 27(1):123-4. PubMed ID: 7123511
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of heparin on the neutralization of factor Xa and thrombin by the plasma alpha-2-globulin inhibitor.
    Yin ET
    Thromb Diath Haemorrh; 1975 Feb; 33(1):43-50. PubMed ID: 47195
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
    Hortin GL; Tollefsen DM; Santoro SA
    Am J Clin Pathol; 1988 Apr; 89(4):515-7. PubMed ID: 3354504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III and heparin.
    Barrowcliffe TW; Johnson EA; Thomas D
    Br Med Bull; 1978 May; 34(2):143-50. PubMed ID: 350337
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma.
    Andersson LO; Barrowcliffe TW; Holmer E; Johnson EA; Söderström G
    Thromb Res; 1979; 15(3-4):531-41. PubMed ID: 494159
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of heparin in the inactivation of thrombin, factor Xa, and plasmin by antithrombin III.
    Stürzebecher J; Markwardt F
    Thromb Res; 1977 Dec; 11(6):835-46. PubMed ID: 146278
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.
    Friberger P
    Semin Thromb Hemost; 1983 Oct; 9(4):281-300. PubMed ID: 6362011
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of heparin cofactor II (HCII) on the determination of antithrombin III (AT).
    Tran TH; Duckert F
    Thromb Res; 1985 Nov; 40(4):571-6. PubMed ID: 3841235
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of factor X and prothrombin in antithrombin-III depleted plasma: the effects of heparin.
    Ofosu FA; Blajchman MA; Modi G; Cerskus AL; Hirsh J
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):331-45. PubMed ID: 7324001
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
    Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI
    Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifactor Xa activity measured with amidolytic methods.
    Odegård OR; Lie M; Abildgaard U
    Haemostasis; 1976; 5(5):265-75. PubMed ID: 1017722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.